Report cover image

C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022 - 2029

Publisher Polaris Market Research & Consulting LLP
Published Jan 01, 2022
Length 128 Pages
SKU # PLRS16991611

Description

C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022 - 2029

The global c-reactive protein testing market size is expected to reach USD 2,158.62 million by 2029 according to a new study by Polaris Market Research. The report “C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022 – 2029” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing heart-related diseases due to the increasing geriatric population, obesity, and others are expected to increase the demand for the industry over the forecast period. Additionally, rising awareness for preventing and treating cardiovascular diseases, along with increasing investments for novel techniques, are expected to propel the industry over the forecast period.

Furthermore, the ongoing COVID-19 pandemic has increased the demand for innovative diagnosis with rapid results, has increased the demand for point-of-care testing, which in turn has benefited the industry and is expected to increase over the forecast period.

Table of Contents

128 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global C-reactive protein Testing Market Insights
4.1. C-reactive protein Testing – Industry Snapshot
4.2. C-reactive protein Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.2. Restraints and Challenges
4.2.3. Porter’s Five Forces Analysis
4.2.3.1. Bargaining Power of Suppliers (Moderate)
4.2.3.2. Threats of New Entrants: (Low)
4.2.3.3. Bargaining Power of Buyers (Moderate)
4.2.3.4. Threat of Substitute (Moderate)
4.2.3.5. Rivalry among existing firms (High)
4.2.4. PESTLE Analysis
4.2.5. C-reactive protein Testing Industry Trends
4.2.6. COVID-19 Impact Analysis
5. Global C-reactive protein Testing Market, by Assay Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
5.3. Immuno-turbidimetric Assay
5.3.1. Global C-reactive protein Testing Market, by Immuno-turbidimetric Assay, by Region, 2017 - 2029 (USD Million)
5.4. ELISA
5.4.1. Global C-reactive protein Testing Market, by ELISA, by Region, 2017 - 2029 (USD Million)
5.4.2. Clinical
5.4.2.1. Global C-reactive protein Testing Market, by Clinical, by Region, 2017 - 2029 (USD Million)
5.4.3. Non-clinical
5.4.3.1. Global C-reactive protein Testing Market, by Non-clinical, by Region, 2017 - 2029 (USD Million)
5.5. Chemiluminescence Immunoassay
5.5.1. Global C-reactive protein Testing Market, by Chemiluminescence Immunoassay, by Region, 2017 - 2029 (USD Million)
5.6. Others
5.6.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)
6. Global C-reactive protein Testing Market, by Detection Range
6.1. Key Findings
6.2. Introduction
6.2.1. Global C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
6.3. hs-CRP
6.3.1. Global C-reactive protein Testing Market, by hs-CRP, by Region, 2017 - 2029 (USD Million)
6.4. Conventional CRP
6.4.1. Global C-reactive protein Testing Market, by Conventional CRP, by Region, 2017 - 2029 (USD Million)
6.5. cCRP
6.5.1. Global C-reactive protein Testing Market, by cCRP, by Region, 2017 - 2029 (USD Million)
7. Global C-reactive protein Testing Market, by Disease Area
7.1. Key Findings
7.2. Introduction
7.2.1. Global C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
7.3. Cardiovascular Diseases
7.3.1. Global C-reactive protein Testing Market, by Cardiovascular Diseases, By Region, 2017 - 2029 (USD Million)
7.4. Cancer
7.4.1. Global C-reactive protein Testing Market, by Cancer, By Region, 2017 - 2029 (USD Million)
7.5. Rheumatoid Arthritis
7.5.1. Global C-reactive protein Testing Market, by Rheumatoid Arthritis, By Region, 2017 - 2029 (USD Million)
7.6. Inflammatory Bowel Disease
7.6.1. Global C-reactive protein Testing Market, by Inflammatory Bowel Disease, By Region, 2017 - 2029 (USD Million)
7.7. Endometriosis
7.7.1. Global C-reactive protein Testing Market, by Endometriosis, By Region, 2017 - 2029 (USD Million)
7.8. Lupus
7.8.1. Global C-reactive protein Testing Market, by Lupus, By Region, 2017 - 2029 (USD Million)
8. Global C-reactive protein Testing Market, by End-Use
8.1. Key Findings
8.2. Introduction
8.2.1. Global C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
8.3. Clinics
8.3.1. Global C-reactive protein Testing Market, By Clinics, By Region, 2017 - 2029 (USD Million)
8.4. Hospitals
8.4.1. Global C-reactive protein Testing Market, by Hospitals, by Region, 2017 - 2029 (USD Million)
8.5. Laboratories
8.5.1. Global C-reactive protein Testing Market, by Laboratories, by Region, 2017 - 2029 (USD Million)
8.6. Assisted Living Healthcare Facilities
8.6.1. Global C-reactive protein Testing Market, by Assisted Living Healthcare Facilities, by Region, 2017 - 2029 (USD Million)
8.7. Home Care Settings
8.7.1. Global C-reactive protein Testing Market, by Home Care Settings, by Region, 2017 - 2029 (USD Million)
8.8. Others
8.8.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)
9. Global C-reactive protein Testing Market, by Geography
9.1. Key findings
9.2. Introduction
9.2.1. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
9.3. C-reactive protein Testing Market – North America
9.3.1. North America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.2. North America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.3. North America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.4. North America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.3.5. C-reactive protein Testing Market – U.S.
9.3.5.1. U.S.: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.5.2. U.S.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.5.3. U.S.: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.5.4. U.S.: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.3.6. C-reactive protein Testing Market – Canada
9.3.6.1. Canada: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.6.2. Canada.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.6.3. Canada: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.6.4. Canada: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4. C-reactive protein Testing Market – Europe
9.4.1. Europe: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.2. Europe.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.3. Europe: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.4. Europe: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.5. C-reactive protein Testing Market – UK
9.4.5.1. UK: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.5.2. UK.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.5.3. UK: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.5.4. UK: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.6. C-reactive protein Testing Market – France
9.4.6.1. France: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.6.2. France.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.6.3. France: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.6.4. France: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.7. C-reactive protein Testing Market – Germany
9.4.7.1. Germany: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.7.2. Germany.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.7.3. Germany: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.7.4. Germany: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.8. C-reactive protein Testing Market – Italy
9.4.8.1. Italy: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.8.2. Italy.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.8.3. Italy: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.8.4. Italy: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.9. C-reactive protein Testing Market – Spain
9.4.9.1. Spain: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.9.2. Spain.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.9.3. Spain: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.9.4. Spain: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.10. C-reactive protein Testing Market – Netherlands
9.4.10.1. Netherlands: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.10.2. Netherlands.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.10.3. Netherlands: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.10.4. Netherlands: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.11. C-reactive protein Testing Market – Austria
9.4.11.1. Austria: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.11.2. Austria.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.11.3. Austria: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.11.4. Austria: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5. C-reactive protein Testing Market – Asia Pacific
9.5.1. Asia Pacific: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.2. Asia Pacific.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.3. Asia pacific: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.4. Asia pacific: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.5. C-reactive protein Testing Market – China
9.5.5.1. China: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.5.2. China.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.5.3. China: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.5.4. China: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.6. C-reactive protein Testing Market – India
9.5.6.1. India: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.6.2. India.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.6.3. India: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.6.4. India: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.7. C-reactive protein Testing Market – Malaysia
9.5.7.1. Malaysia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.7.2. Malaysia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.7.3. Malaysia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.7.4. Malaysia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.8. C-reactive protein Testing Market – Japan
9.5.8.1. Japan: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.8.2. Japan.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.8.3. Japan: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.8.4. Japan: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.9. C-reactive protein Testing Market – Indonesia
9.5.9.1. Indonesia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.9.2. Indonesia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.9.3. Indonesia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.9.4. Indonesia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.10. C-reactive protein Testing Market – South Korea
9.5.10.1. South Korea: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.10.2. South Korea.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.10.3. South Korea: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.10.4. South Korea: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6. C-reactive protein Testing Market – Middle East & Africa
9.6.1. Middle East & Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.2. Middle East & Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.3. Middle East & Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.4. Middle East & Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.5. C-reactive protein Testing Market – Saudi Arabia
9.6.5.1. Saudi Arabia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.5.2. Saudi Arabia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.5.3. Saudi Arabia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.5.4. Saudi Arabia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.6. C-reactive protein Testing Market – UAE
9.6.6.1. UAE: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.6.2. UAE.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.6.3. UAE: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.6.4. UAE: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.7. C-reactive protein Testing Market – Israel
9.6.7.1. Israel: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.7.2. Israel.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.7.3. Israel: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.7.4. Israel: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.8. C-reactive protein Testing Market – South Africa
9.6.8.1. South Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.8.2. South Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.8.3. South Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.8.4. South Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7. C-reactive protein Testing Market – Latin America
9.7.1. Latin America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.2. Latin America.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.3. Latin America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.4. Latin America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.5. C-reactive protein Testing Market – Mexico
9.7.5.1. Mexico: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.5.2. Mexico.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.5.3. Mexico: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.5.4. Mexico: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.6. C-reactive protein Testing Market – Brazil
9.7.6.1. Brazil: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.6.2. Brazil.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.6.3. Brazil: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.6.4. Brazil: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.7. C-reactive protein Testing Market – Argentina
9.7.7.1. Argentina: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.7.2. Argentina.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.7.3. Argentina: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.7.4. Argentina: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Abaxis, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Abbott
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Aidian
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. BODITECH MED, INC
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Danaher
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. F. Hoffmann-La Roche Ltd.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Getein Biotech, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. HORIBA, Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Laboratory Corporation of America Holdings
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Ortho Clinical Diagnostics
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Quest Diagnostics
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development
11.13. Randox Laboratories Ltd.
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Benchmarking
11.13.4. Recent Development
11.14. Roche Ltd.
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Benchmarking
11.14.4. Recent Development
11.15. Siemens Healthineers AG
11.15.1. Company Overview
11.15.2. Financial Performance
11.15.3. Product Benchmarking
11.15.4. Recent Development
11.16. Thermo Fisher Scientific, Inc.
11.16.1. Company Overview
11.16.2. Financial Performance
11.16.3. Product Benchmarking
11.16.4. Recent Development
11.17. Zoetis
11.17.1. Company Overview
11.17.2. Financial Performance
11.17.3. Product Benchmarking
11.17.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us